Michael Deem is an experienced senior professional who has operated in senior management, Board, and advisor capacities with companies ranging from start-up, to rapid growth, to large multi-national companies. Deem is currently a General Partner at SmartHealth Catalyzer and CEO of a startup. Deem was the director of Drug Design at CuraGen Corporation ($100M exit). He was the 3rd person and performed all the original engineering calculations at Ion Torrent Systems ($2.3B exit). Michael W Deem


His intellectual bandwidth has benefited companies from a wide cross section of industries that include Life Sciences, Artificial Intelligence, Genomics, Data Science, Biotechnology, Energy, and Cancer Research.